The HIV − 1 protease inhibitor Amprenavir targets Leishmania donovani topoisomerase I and induces oxidative stress-mediated programmed cell death
Publication date: June 2021Source: Parasitology International, Volume 82Author(s): Amit Roy, Sachidananda Behera, Priyanka H. Mazire, Bhavini Kumari, Abhishek Mandal, Bidyut Purkait, Payel Ghosh, Prolay Das, Pradeep Das
Source: Parasitology International - Category: Parasitology Source Type: research
More News: HIV-Leishmania Co-infection | Parasitology